This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (683) Precision Medicine (159) Clinical Cancer Research (116) Skin Cancer and Melanoma Prevention (123)

Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/55723, first published .
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE): Protocol for a Translational Study

Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE): Protocol for a Translational Study

Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE): Protocol for a Translational Study

Authors of this article:

Emma Belfrage1 Author Orcid Image ;   Sara Ek2 Author Orcid Image ;   Åsa Johansson3 Author Orcid Image ;   Hanna Brauner4, 5 Author Orcid Image ;   Andreas Sonesson1 Author Orcid Image ;   Kristina Drott6 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics

Journals

  1. Johansson A, Kalliara E, Belfrage E, Alling T, Pyl P, Gerdtsson A, Gullberg U, Porwit A, Drott K, Ek S. The Progression of Mycosis Fungoides During Treatment with Mogamulizumab: A BIO-MUSE Case Study of the Tumor and Immune Response in Peripheral Blood and Tissue. Biomedicines 2025;13(1):186 View